OSF Little Company of Mary, in participation with SWOG, is offering a clinical trial to breast cancer patients. SWOG is a worldwide network of researchers that design and conduct cancer clinical trials. The group's goal is to change medical practice so it improves the lives of people with cancer. SWOG trials test new ways to diagnose and treat cancer, as well as prevent it. SWOG researchers also study ways to improve the care cancer patients receive, and improve quality of life for both patients and survivors.
Clinical Trials Currently Open
- A011401: Randomized Phase III Trial Evaluating the Role of Weight Loss In Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
- A011502: A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Postive HER2 Negative Breast Cancer: The ABC Trial
- S1714: A Prospective Observational Cohort Study to Develop A Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients
- A211601: Evaluation of Mammographic Breast Density Effect of Aspirin – A Companion Study to Alliance A011502
Bassel M. Atassi, MD Hematologist / Oncologist
Clinical Research Coordinator